首页 > 最新文献

Journal of the Practice of Cardiovascular Sciences最新文献

英文 中文
Electrocardiographic changes in pregnant women with COVID-19 新冠肺炎孕妇心电图变化
IF 0.1 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-01-01 DOI: 10.4103/jpcs.jpcs_9_22
Mojtaba Yousefzadeh, A. Asgarian, R. Ahangari, M. Vahedian, Monireh Mirzaie
Introduction: One of the unique challenges for obstetricians in pregnancy is cardiovascular changes. This study aimed to evaluate electrocardiographic (ECG) changes in mothers with COVID-19. Materials and Methods: In a retrospective study, 89 pregnant women with positive reverse transcription-polymerase chain reaction for COVID-19, between 19 and 44 years old, were selected for the study, and 12 lead ECGs were extracted and recorded from the medical documents for all cases and all parameters analyzed. Results: Of the 89 patients that met inclusion criteria, only eight patients were admitted to intensive care unit. Of all, 64 cases (71.9%) had normal ECG, three patients showed atrioventricular (AV) block (3.4%), and three patients had first-degree AV block type (PR interval >200 ms). The mean QTC interval was 428.6 ± 37.4 ms and 15 (17%) patients had long QTC intervals (QTC ≥460 ms). There was a significant relationship between antivirus treatment (P = 0.027), as well as hydroxychloroquine (HCQ) with PR interval (P = 0.002). A significant relationship was found between corticosteroids with QTC (P = 0.019) and antibiotics with QTC (P = 0.018). Conclusion: A significant association between corticosteroids usage and QTC interval as well as antiviral and HCQ treatment with PR interval. These changes during pregnancy and COVID-19 should be interpreted with caution by physicians. Understanding changes in electrocardiography can help in better and early diagnosis and management of pregnant mothers to prevent adverse outcomes.
引言:产科医生在怀孕期间面临的独特挑战之一是心血管变化。本研究旨在评估新冠肺炎母亲的心电图变化。材料和方法:在一项回顾性研究中,选择89名19至44岁的新冠肺炎逆转录聚合酶链式反应阳性孕妇进行研究,并从所有病例的医学文件中提取和记录12个导联心电图,分析所有参数。结果:在符合入选标准的89名患者中,只有8名患者入住重症监护室。其中64例(71.9%)心电图正常,3例房室传导阻滞(3.4%),3例一级房室传导阻滞型(PR间期>200ms)。平均QTC间期为428.6±37.4ms,15例(17%)患者QTC间期较长(QTC≥460ms)。抗病毒治疗之间存在显著相关性(P=0.027),以及羟氯喹(HCQ)与PR间期的相关性(P=0.002)。皮质类固醇与QTC(P=0.019)和抗生素与QTC之间存在显著关系(P=0.018)。医生应谨慎解释妊娠和新冠肺炎期间的这些变化。了解心电图的变化有助于更好地早期诊断和管理孕妇,以防止不良后果。
{"title":"Electrocardiographic changes in pregnant women with COVID-19","authors":"Mojtaba Yousefzadeh, A. Asgarian, R. Ahangari, M. Vahedian, Monireh Mirzaie","doi":"10.4103/jpcs.jpcs_9_22","DOIUrl":"https://doi.org/10.4103/jpcs.jpcs_9_22","url":null,"abstract":"Introduction: One of the unique challenges for obstetricians in pregnancy is cardiovascular changes. This study aimed to evaluate electrocardiographic (ECG) changes in mothers with COVID-19. Materials and Methods: In a retrospective study, 89 pregnant women with positive reverse transcription-polymerase chain reaction for COVID-19, between 19 and 44 years old, were selected for the study, and 12 lead ECGs were extracted and recorded from the medical documents for all cases and all parameters analyzed. Results: Of the 89 patients that met inclusion criteria, only eight patients were admitted to intensive care unit. Of all, 64 cases (71.9%) had normal ECG, three patients showed atrioventricular (AV) block (3.4%), and three patients had first-degree AV block type (PR interval >200 ms). The mean QTC interval was 428.6 ± 37.4 ms and 15 (17%) patients had long QTC intervals (QTC ≥460 ms). There was a significant relationship between antivirus treatment (P = 0.027), as well as hydroxychloroquine (HCQ) with PR interval (P = 0.002). A significant relationship was found between corticosteroids with QTC (P = 0.019) and antibiotics with QTC (P = 0.018). Conclusion: A significant association between corticosteroids usage and QTC interval as well as antiviral and HCQ treatment with PR interval. These changes during pregnancy and COVID-19 should be interpreted with caution by physicians. Understanding changes in electrocardiography can help in better and early diagnosis and management of pregnant mothers to prevent adverse outcomes.","PeriodicalId":17503,"journal":{"name":"Journal of the Practice of Cardiovascular Sciences","volume":"8 1","pages":"17 - 21"},"PeriodicalIF":0.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42986658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Thrombolysis in the de winter electrocardiography pattern: A therapeutic dilemma 冬季心电图模式中的溶栓:治疗困境
IF 0.1 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-01-01 DOI: 10.4103/jpcs.jpcs_4_22
Amit Kumar, Rajesh Chetiwal, Shweta Tanwar, Sudhish Gupta, Rohit Kumar
The de Winter's pattern is an electrocardiography (ECG) finding characterized by ST depression and tall prominent T-waves in precordial leads with ST elevation in lead aVR. It signifies the occlusion of proximal left anterior descending artery (LAD). Although it is considered a ST-elevation myocardial infarction (STEMI) equivalent, current guidelines recommend against the use of thrombolytic therapy in the absence of STEMI. As the question whether to use thrombolysis in such situations remains unanswered and controversial, we preferred to provide thrombolytic therapy with tenecteplase to our patient admitted with acute retrosternal chest pain with de Winter's ECG pattern so as to prevent myocardial damage and improve the patient outcome as the percutaneous coronary intervention facility was not immediately available. The thrombolysis was successful and the proximal LAD occlusion was confirmed later on coronary angiography which was treated with stent implantation. This case report tends to highlight the therapeutic dilemma while managing patients with de Winter's ECG pattern.
de Winter型是一种心电图(ECG)发现,其特征是心前导联ST段下降和高且突出的t波,aVR导联ST段升高。表示左前降支近端闭塞。虽然它被认为是st段抬高型心肌梗死(STEMI)等效,但目前的指南不建议在没有STEMI的情况下使用溶栓治疗。由于在这种情况下是否使用溶栓仍然是一个没有答案和有争议的问题,我们更倾向于对我们入院的急性胸骨后胸痛伴有de Winter心电图模式的患者提供tenecteplase溶栓治疗,以防止心肌损害,改善患者的预后,因为经皮冠状动脉介入治疗设备不能立即获得。溶栓成功,后经冠状动脉造影证实LAD近端闭塞,并行支架植入治疗。本病例报告倾向于强调在处理德温特心电图模式患者时的治疗困境。
{"title":"Thrombolysis in the de winter electrocardiography pattern: A therapeutic dilemma","authors":"Amit Kumar, Rajesh Chetiwal, Shweta Tanwar, Sudhish Gupta, Rohit Kumar","doi":"10.4103/jpcs.jpcs_4_22","DOIUrl":"https://doi.org/10.4103/jpcs.jpcs_4_22","url":null,"abstract":"The de Winter's pattern is an electrocardiography (ECG) finding characterized by ST depression and tall prominent T-waves in precordial leads with ST elevation in lead aVR. It signifies the occlusion of proximal left anterior descending artery (LAD). Although it is considered a ST-elevation myocardial infarction (STEMI) equivalent, current guidelines recommend against the use of thrombolytic therapy in the absence of STEMI. As the question whether to use thrombolysis in such situations remains unanswered and controversial, we preferred to provide thrombolytic therapy with tenecteplase to our patient admitted with acute retrosternal chest pain with de Winter's ECG pattern so as to prevent myocardial damage and improve the patient outcome as the percutaneous coronary intervention facility was not immediately available. The thrombolysis was successful and the proximal LAD occlusion was confirmed later on coronary angiography which was treated with stent implantation. This case report tends to highlight the therapeutic dilemma while managing patients with de Winter's ECG pattern.","PeriodicalId":17503,"journal":{"name":"Journal of the Practice of Cardiovascular Sciences","volume":"8 1","pages":"48 - 50"},"PeriodicalIF":0.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43855169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic targets in the management of atrial fibrillation in patients with cardiomyopathy 遗传靶点在心肌病患者心房颤动治疗中的作用
IF 0.1 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-01-01 DOI: 10.4103/jpcs.jpcs_65_21
M. Zigova, E. Petrejčíková, M. Blascáková, J. Kmec, J. Bernasovská, I. Boroňová, Martin Kmec
Cardiomyopathies are heterogeneous health conditions with the potential for atrial fibrillation. The management of patients with cardiomyopathy accompanied by atrial fibrillation is complicated by the maintenance of sinus rhythm, toxicity, or other complications. There is a lack of information about the reasons for therapy response heterogeneity or therapy failure. Our searching strategy of scientific databases declares a potentially important role of genetics in patients' management. The promising target could be the 4q25 locus and its sequence variants. Molecular-genetic analyses may shed new light on anti-atrial fibrillation therapy in cardiomyopathy patients and help reveal the genetic subtypes of cardiomyopathy patients. In this sense, the purpose of our study is to examine the evidence for genetic variation influencing the efficacy of pharmacological or invasive therapies for atrial fibrillation, especially at the 4q25 locus, in cardiomyopathy patients and declare the importance of detected genetic markers responsible for positive or negative responses to specific anti-atrial fibrillation therapies.
心肌病是具有房颤潜在的异质性健康状况。心肌病合并心房颤动患者的治疗因维持窦性心律、毒性或其他并发症而复杂化。关于治疗反应异质性或治疗失败的原因缺乏信息。我们对科学数据库的搜索策略表明遗传学在患者管理中具有潜在的重要作用。有希望的目标可能是4q25位点及其序列变体。分子遗传学分析可能为心肌病患者的抗房颤治疗提供新的思路,并有助于揭示心肌病患者的遗传亚型。从这个意义上说,我们研究的目的是研究影响房颤药物或侵入性治疗疗效的遗传变异的证据,特别是在4q25位点,心肌病患者,并宣布检测到的遗传标记对特定抗房颤治疗的阳性或阴性反应的重要性。
{"title":"Genetic targets in the management of atrial fibrillation in patients with cardiomyopathy","authors":"M. Zigova, E. Petrejčíková, M. Blascáková, J. Kmec, J. Bernasovská, I. Boroňová, Martin Kmec","doi":"10.4103/jpcs.jpcs_65_21","DOIUrl":"https://doi.org/10.4103/jpcs.jpcs_65_21","url":null,"abstract":"Cardiomyopathies are heterogeneous health conditions with the potential for atrial fibrillation. The management of patients with cardiomyopathy accompanied by atrial fibrillation is complicated by the maintenance of sinus rhythm, toxicity, or other complications. There is a lack of information about the reasons for therapy response heterogeneity or therapy failure. Our searching strategy of scientific databases declares a potentially important role of genetics in patients' management. The promising target could be the 4q25 locus and its sequence variants. Molecular-genetic analyses may shed new light on anti-atrial fibrillation therapy in cardiomyopathy patients and help reveal the genetic subtypes of cardiomyopathy patients. In this sense, the purpose of our study is to examine the evidence for genetic variation influencing the efficacy of pharmacological or invasive therapies for atrial fibrillation, especially at the 4q25 locus, in cardiomyopathy patients and declare the importance of detected genetic markers responsible for positive or negative responses to specific anti-atrial fibrillation therapies.","PeriodicalId":17503,"journal":{"name":"Journal of the Practice of Cardiovascular Sciences","volume":"8 1","pages":"9 - 16"},"PeriodicalIF":0.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48952969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and angiographic characteristics of coronary artery ectasia and its correlation with high-sensitivity c-reactive protein and serum uric acid 冠状动脉扩张的临床和造影特征及其与高敏c反应蛋白和血清尿酸的关系
IF 0.1 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-01-01 DOI: 10.4103/jpcs.jpcs_24_22
K. Parvathareddy, S. Maale, Praveen Nagula, Srinivas Ravi, Monica Rayapu, N. Balla
{"title":"Clinical and angiographic characteristics of coronary artery ectasia and its correlation with high-sensitivity c-reactive protein and serum uric acid","authors":"K. Parvathareddy, S. Maale, Praveen Nagula, Srinivas Ravi, Monica Rayapu, N. Balla","doi":"10.4103/jpcs.jpcs_24_22","DOIUrl":"https://doi.org/10.4103/jpcs.jpcs_24_22","url":null,"abstract":"","PeriodicalId":17503,"journal":{"name":"Journal of the Practice of Cardiovascular Sciences","volume":"1 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70814929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pseudoaneurysm formation between ascending aorta and main pulmonary artery following ventricular septal defect patch dehiscence 室间隔缺损斑块破裂后在升主动脉与肺动脉主动脉之间形成假性动脉瘤
IF 0.1 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-01-01 DOI: 10.4103/jpcs.jpcs_70_22
Jigisha Pujara, Guriqbal Singh, Mrugesh Prajapati, T. Gajjar, Bhavik Chimpaneri, Pavan Patel
{"title":"Pseudoaneurysm formation between ascending aorta and main pulmonary artery following ventricular septal defect patch dehiscence","authors":"Jigisha Pujara, Guriqbal Singh, Mrugesh Prajapati, T. Gajjar, Bhavik Chimpaneri, Pavan Patel","doi":"10.4103/jpcs.jpcs_70_22","DOIUrl":"https://doi.org/10.4103/jpcs.jpcs_70_22","url":null,"abstract":"","PeriodicalId":17503,"journal":{"name":"Journal of the Practice of Cardiovascular Sciences","volume":"1 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70816678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Macro T-Wave alternans in recurrent orthodromic atrioventricular reentrant tachycardia 复发性正交性房室折返性心动过速的宏观T波交替
IF 0.1 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-01-01 DOI: 10.4103/jpcs.jpcs_52_21
Debasish Das, Tutan Das, Subhash R. Pramanik
{"title":"Macro T-Wave alternans in recurrent orthodromic atrioventricular reentrant tachycardia","authors":"Debasish Das, Tutan Das, Subhash R. Pramanik","doi":"10.4103/jpcs.jpcs_52_21","DOIUrl":"https://doi.org/10.4103/jpcs.jpcs_52_21","url":null,"abstract":"","PeriodicalId":17503,"journal":{"name":"Journal of the Practice of Cardiovascular Sciences","volume":"8 1","pages":"68 - 69"},"PeriodicalIF":0.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47633395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-COVID-19 cardiovascular syndrome: What does the evidence tell us? COVID-19后心血管综合征:证据告诉我们什么?
IF 0.1 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-01-01 DOI: 10.4103/jpcs.jpcs_69_21
I. Lozada-Martinez, Geiro Pava-Barrios, Andres Yoli-Garrido, Anderson Leal-Buitrago, Nicolas Rodriguez-Medina
{"title":"Post-COVID-19 cardiovascular syndrome: What does the evidence tell us?","authors":"I. Lozada-Martinez, Geiro Pava-Barrios, Andres Yoli-Garrido, Anderson Leal-Buitrago, Nicolas Rodriguez-Medina","doi":"10.4103/jpcs.jpcs_69_21","DOIUrl":"https://doi.org/10.4103/jpcs.jpcs_69_21","url":null,"abstract":"","PeriodicalId":17503,"journal":{"name":"Journal of the Practice of Cardiovascular Sciences","volume":"8 1","pages":"65 - 67"},"PeriodicalIF":0.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49407316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New year – A newer avenue for heart failure pharmacotherapy 新的一年——心力衰竭药物治疗的新途径
IF 0.1 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-01-01 DOI: 10.4103/jpcs.jpcs_1_22
Jes Jose, Iti Shri, R. Magoon, Sparsh Bhalla
{"title":"New year – A newer avenue for heart failure pharmacotherapy","authors":"Jes Jose, Iti Shri, R. Magoon, Sparsh Bhalla","doi":"10.4103/jpcs.jpcs_1_22","DOIUrl":"https://doi.org/10.4103/jpcs.jpcs_1_22","url":null,"abstract":"","PeriodicalId":17503,"journal":{"name":"Journal of the Practice of Cardiovascular Sciences","volume":"8 1","pages":"70 - 71"},"PeriodicalIF":0.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46309537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure a multinational randomized trial (The EMPULSE Trial) SGLT2抑制剂恩格列净在急性心力衰竭住院患者中的应用:一项多国随机试验(EMPULSE试验)
IF 0.1 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-01-01 DOI: 10.4103/jpcs.jpcs_34_22
S. Sardar
{"title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure a multinational randomized trial (The EMPULSE Trial)","authors":"S. Sardar","doi":"10.4103/jpcs.jpcs_34_22","DOIUrl":"https://doi.org/10.4103/jpcs.jpcs_34_22","url":null,"abstract":"","PeriodicalId":17503,"journal":{"name":"Journal of the Practice of Cardiovascular Sciences","volume":"1 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70815536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Role of Indian fruits in the prevention and management of hypertension 印度水果在预防和管理高血压中的作用
IF 0.1 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-01-01 DOI: 10.4103/jpcs.jpcs_63_22
Pankaj Prabhakar
{"title":"Role of Indian fruits in the prevention and management of hypertension","authors":"Pankaj Prabhakar","doi":"10.4103/jpcs.jpcs_63_22","DOIUrl":"https://doi.org/10.4103/jpcs.jpcs_63_22","url":null,"abstract":"","PeriodicalId":17503,"journal":{"name":"Journal of the Practice of Cardiovascular Sciences","volume":"1 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70815961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the Practice of Cardiovascular Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1